Stockreport

FibroBiologics Announces Closing of $3 Million Public Offering

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ p [Read more]